Oxybuprocaine, Fluorescein

Colirofta Fluotest 2,5 MG/ML + 4 MG/ML Colirio en Solución

4 mg + 2,5 mg colirio en soluciónSpainWithdrawnAuthorised 30 Sept 1992

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Fluorescein Sodium & Benoxinate Hydrochloride Ophthalmic Solution, USPCanada · 0.4 % + 0.25 % · Solution · Bausch & Lomb INCSame substance
FluoroxCanada · 0.4 % + 0.25 % · Solution · White Ophthalmic Services & Supply Co LTDSame substance
FluressCanada · 0.4 % + 0.25 % · Solution · Akorn INCSame substance
Altafluor BenoxUnited States · 0.4%; 0.25% · solution/drops · Altaire Pharms INCSame substance
Fluorescein Sodium and Benoxinate HydrochlorideUnited States · 0.4%; 0.3% · solution/drops · Bausch Lomb IrelandSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Oxybuprocaine, Fluorescein

Colirofta Fluotest 2,5 MG/ML + 4 MG/ML Colirio en Solución

4 mg + 2,5 mg colirio en soluciónSpainWithdrawnAuthorised 30 Sept 1992

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
COLIROFTA FLUOTEST 2,5 MG/ML + 4 MG/ML COLIRIO EN SOLUCIÓN, 1 frasco de 3 ml	653452

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Oxybuprocaine, Fluorescein
Strength: 4 mg + 2,5 mg
Dosage form: colirio en solución
Route: vía oftálmica
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 30 Sept 1992
Registration: 59104
Marketing authorisation holder: Alcon Healthcare S.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica